At-home genetic kits don't reveal all breast cancer risks
Millions of people have bought into the mail-in DNA testing craze, but a new study indicates consumers should be aware of the limitations of the health tests offered.   Those who expect 23andMe to detect most breast cancer risks are being cautioned after study findings determined almost 90 percent of participants with a BRCA mutation wouldn’t have received a positive from the company’s test, reports The New York Times. The test’s limited scope is to bla me, per The Daily Beast. The study,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Caitlin Mullen Source Type: news

How Various Breast Cancer Screening Guidelines Compare
In this slideshow, various clinical guidelines on breast cancer screening are summarized, including the ACP's recent recommendations that have come under some scrutiny. (Source: CancerNetwork)
Source: CancerNetwork - April 19, 2019 Category: Cancer & Oncology Authors: Lori Smith, BSN, MSN, CRNP Source Type: news

Medical News Today: Breast cancer: Reducing this amino acid could make drugs more effective
New research in cell cultures and mice reveals a surprising link between the essential amino acid leucine and resistance to tamoxifen in breast cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 18, 2019 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Breast Cancer Genetic Testing Guidelines'Simply Are Not Effective'Breast Cancer Genetic Testing Guidelines'Simply Are Not Effective '
Kathy Miller discusses current breast cancer genetic testing guidelines and considerations for more widespread genetic testing.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Tanzania: Experts Push for Improvement of Referral Pattern
[Daily News] HEALTH practitioners have recommended the improvement of the country's referral pattern to facilitate earlier diagnosis of breast cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 18, 2019 Category: African Health Source Type: news

Women benefit from ACA's ban on mammography co-pays
The Patient Protection and Affordable Care Act's (ACA) elimination of co-pays...Read more on AuntMinnie.comRelated Reading: ACA has benefited low- and middle-income women Out-of-pocket costs keep women from mammo follow-up How has the ACA affected breast cancer screening? Almost 25% of women pay out-of-pocket costs for mammography More women get breast screening after ACA bans copays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 18, 2019 Category: Radiology Source Type: news

Simple blood test can spot if breast cancer will return up to TWO YEARS earlier than current scans
A study by the University of Leicester and Imperial College London looked for mutant DNA released from dying tumours in the blood of 49 breast-cancer patients over several years (stock) (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2019 Category: Consumer Health News Source Type: news

Diet high in leucine may fuel breast cancer's drug resistance
(Beth Israel Deaconess Medical Center) A team led by Senthil Muthuswamy, PhD, at the Cancer Center at Beth Israel Deaconess Medical Center, has discovered an unexpected relationship between levels of the amino acid leucine (found in beef, chicken, pork and fish and other foods) and the development of tamoxifen resistance in ER+ breast cancer. These findings reveal a potential new strategy for overcoming resistance to endocrine drugs in ER+ breast cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

Preventing triple negative breast cancer from spreading
(University of Missouri-Columbia) A protein called p53 suppresses and kills cancer in people. However, a defective, mutant form of p53 helps cancer cells grow and multiply. Researchers at the University of Missouri have now found that a combination drug therapy reduces the spread of triple negative breast cancer to other locations of the body by 50 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

Triple negative breast cancers can adopt reversible state that is resistant to chemotherapy
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2019 Category: Biology Source Type: news

Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects
(Institute for Quality and Efficiency in Health Care) Study indicates longer overall survival of postmenopausal women. However, there is a higher frequency of severe diseases of blood and lymphatic system. Overall, added benefit not proven. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Partner status influences sexual problems and self-efficacy in survivors of breast cancer
(The North American Menopause Society (NAMS)) Vaginal dryness and painful intercourse are some of the more common adverse events of post-breast cancer treatment therapies and often lead to sexual dissatisfaction and an overall lower quality of life (QOL). However, a new study finds that partnered women may fare better than those without a partner. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

EC Approves Olaparib for BRCA Breast Cancer EC Approves Olaparib for BRCA Breast Cancer
The European Commission has cleared olaparib (Lynparza, AstraZeneca/MSD) for the treatment of locally advanced or metastatic BRCA1/2 breast cancer.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Don ’ t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. (Source: NYT Health)
Source: NYT Health - April 16, 2019 Category: Consumer Health News Authors: HEATHER MURPHY Tags: Genetics and Heredity Tests (Medical) Breast Cancer DNA (Deoxyribonucleic Acid) Ovarian Cancer 23andMe Promethease (SNPedia) Invitae Corp. Source Type: news

Tool Calculates Competing Risks of Death in Older Women With Early Breast Cancer Tool Calculates Competing Risks of Death in Older Women With Early Breast Cancer
A risk calculator incorporating age, comorbidities and estrogen receptor status can estimate competing risks of death for older women with stage 1 breast cancer, potentially aiding therapeutic decision making, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 16, 2019 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Elastography can help characterize breast tumors
Breast elastography is an overlooked tool for evaluating breast cancer, especially...Read more on AuntMinnie.comRelated Reading: Density notification laws boost breast ultrasound use AI characterizes breast masses on ultrasound Study questions value of supplemental breast ultrasound ABUS better than DBT for diagnostic workup CAD boosts reader performance for breast ultrasound (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 16, 2019 Category: Radiology Source Type: news

Summit empowers women to take charge of their brain health
UCLA alumna  and singer-songwriter Sara Bareilles blew the roof off a packed ballroom with her powerful performance of her anthem, “Brave,” setting the tone for a day of self-discovery and conversation about mental health at the Wonder of Women Summit on April 11.Johnese Spisso, president of UCLA Health, welcomed 500 attendees to the star-studded occasion, which melded the cream of Hollywood celebrities with UCLA trailblazers in fields ranging from medicine to athletics.Emceed by actress Lisa Kudrow, the event was hosted by UCLA ’s Friends of the Semel Institute and Resnick Neuropsychiatric Hospital ...
Source: UCLA Newsroom: Health Sciences - April 15, 2019 Category: Universities & Medical Training Source Type: news

Genetic Testing Under-Utilized in Ovarian Cancer Genetic Testing Under-Utilized in Ovarian Cancer
Only a minority of women with ovarian or breast cancer undergo recommended genetic testing, a new study suggests.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - April 15, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Cancer-Related Insomnia: New Research Finds Effective Treatments
This study was a first of its kind. It involved a head-to-head comparison of acupuncture and cognitive behavioral therapy, enrolled patients with many different types of cancer and included nearly 30% minority participants. Previous studies focused solely on breast cancer and included 90% white participants. Limitations of the previous research make it difficult to determine if the results are applicable to patients with other cancers and people of diverse backgrounds. Cognitive Behavioral Therapy and Acupuncture Are Effective Acupuncture and cognitive behavioral therapy treatments produced clinically meaningful reduction...
Source: Asbestos and Mesothelioma News - April 15, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Dr. Schmidt on AMAROS Trial Results: Radiotherapy vs Surgery of the Axilla in Breast Cancer
Cancer Network spoke with Hank Schmidt, MD, about the 10-year follow-up results of the EORTC AMAROS trial of radiotherapy vs surgery of the axilla in breast cancer patients with a positive sentinel node. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2019 Category: Cancer & Oncology Authors: Hank Schmidt, MD Source Type: news

Precise decoding of breast cancer cells creates new option for treatment
(University of Zurich) Researchers at the University of Zurich and from IBM Research have investigated the vary-ing composition of cancer and immune cells in over one hundred breast tumors. They've found that aggressive tumors are often dominated by a single type of tumor cell. If certain immune cells are present as well, an immune therapy could be successful for a specific group of breast cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

GOOD WORKS SA: Susan G. Komen, Beldon family ready to run in 2019
Every dollar raised from the local Race for the Cure event is spent here, the executive director of the breast cancer-focused nonprofit's San Antonio affiliate said. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2019 Category: Biotechnology Authors: Andi Rodriguez Source Type: news

Dietary Patterns and the Risk of Breast Cancer Dietary Patterns and the Risk of Breast Cancer
A diet high in red meat and high-fat dairy products may be associated with an increased risk of breast cancer.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Seven-Year Follow-Up Results Can Help HER2+ Breast Cancer Patients Avoid Overtreatment
The combination of trastuzumab and paclitaxel'represents an important step forward in de-escalating therapy'for HER2+ breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 12, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Twin sisters, 32, diagnosed with breast cancer just three months apart
Ashley Huffman, 32, from Michigan, was diagnosed with breast cancer in November 2018. Her twin sister, Danielle Jones, was diagnosed just three months later in February 2019. (Source: the Mail online | Health)
Source: the Mail online | Health - April 11, 2019 Category: Consumer Health News Source Type: news

Elucent Medical wins FDA nod for EnVisio breast surgery navigation device
Elucent Medical said today that it won FDA 510(k) clearance for its EnVisio surgical navigation system. The Eden Prairie, Minn.-based company said that the EnVisio navigation system is designed for use in conjunction with the company’s SmartClip soft tissue marker during breast cancer procedures. The SmartClip soft tissue marker is an alternative to hook-wire localization procedures used to identify malignant tissue for removal, the company said. When used with the Envisio system allows physicians to mark difficult lesions and navigate distances, depths and directions in real-time 3D during breast cancer procedures. ...
Source: Mass Device - April 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Surgical Elucent Medical Source Type: news

Barriers of Access to Breast Reconstruction Barriers of Access to Breast Reconstruction
Are all breast cancer patients offered the option of breast reconstruction? What strategies may help improve access to care?Plastic and Reconstructive Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2019 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news

DBT boosts diagnosis of additional breast cancer
Adding digital breast tomosynthesis (DBT) to digital mammography boosts diagnostic...Read more on AuntMinnie.comRelated Reading: SBI: AI improves DBT's performance in dense tissue SBI: DBT users aren't implementing synthesized 2D DBT screening mammography benefits women over 65 Synthesized 2D mammography works just as well as FFDM Breast tissue seems less dense on DBT scans (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 11, 2019 Category: Radiology Source Type: news

Cognitive-Behavioral Therapy Reduces Endocrine Tx Side Effects Cognitive-Behavioral Therapy Reduces Endocrine Tx Side Effects
Cognitive-behavioral therapy may offer breast cancer patients an option to manage the side effects of adjuvant endocrine therapy, according to a new study.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 10, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news

Recurrence Score May Cut Costs for High - Risk Breast Cancer Care
Testing with 21 - gene assay linked to lower relative, absolute costs among high - risk patients (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 10, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news

Recurrence Score May Cut Costs for High-Risk Breast Cancer Care
WEDNESDAY, April 10, 2019 -- Genomic recurrence score (RS) testing using a 21-gene assay is associated with decreased cancer care costs in real-world practice among certain patients with breast cancer who would otherwise receive standard... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 10, 2019 Category: Pharmaceuticals Source Type: news

Women with deadliest form of breast cancer could be saved after simple test found by scientists
Triple negative breast cancer is so aggressive it can resist chemotherapy. Scientists at Queen's University Belfast have discovered a test which could detect the women most at risk. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2019 Category: Consumer Health News Source Type: news

Private hospitals must share more data with NHS, says top surgeon
Ian Paterson scandal prompts call for more oversight of safety in private hospitalsThe leader of the UK ’s surgeons is calling for private hospitals to be encouraged to publish information on their safety to prevent another scandal like the one involving jailed breast cancer surgeon Ian Paterson.“The surgical community was deeply shocked by the case of Ian Paterson, the surgeon convicted of intentionally wounding patients by carrying out unnecessary breast surgery operations,” said Prof Derek Alderson, president of the Royal College of Surgeons.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 10, 2019 Category: Science Authors: Sarah Boseley Health editor Tags: Health Private healthcare Hospitals NHS Breast cancer Society UK news Science Care Quality Commission (CQC) Source Type: news

Contralateral prophylactic mastectomy: Mayo Clinic Radio Health Minute
It's not uncommon for women undergoing mastectomy to treat breast cancer to also have their healthy breast ?removed. ?It's called contralateral prophylactic mastectomy. ?But the American Academy of Breast Surgeons is not recommending the practice, at least not for all women. ?In this Mayo Clinic Radio Health Minute, Dr. Judy Boughey explains why. To listen, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 10, 2019 Category: Databases & Libraries Source Type: news

NICE rules against new hormone therapy combo for breast cancer
Draft guidance on ribociclib with fluvestrant under consultation Related items fromOnMedica NICE rejects adjuvant use of breast cancer drug Breast cancer deaths down due to screening and new therapies New breast cancer drug ‘unaffordable’ for NHS Red tape delaying availability of new cancer drugs One in 10 children in phase I cancer trials respond to drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 10, 2019 Category: UK Health Source Type: news

Genetic Testing Underused in Breast, Ovarian Cancer
TUESDAY, April 9, 2019 -- Only one-quarter of those with breast cancer and one-third with ovarian cancer undergo genetic testing, according to a study published online April 9 in the Journal of Clinical Oncology. Allison W. Kurian, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2019 Category: Pharmaceuticals Source Type: news

Family Doctors Suggest New Mammogram Guidelines
Compared with yearly screening, biannual mammograms do not significantly boost the average woman's risk of death from breast cancer. And they greatly reduce the potential harms, the American Council of Physicians said. (Source: WebMD Health)
Source: WebMD Health - April 9, 2019 Category: Consumer Health News Source Type: news

ACP: Breast Cancer Screening Every 2 Years ACP: Breast Cancer Screening Every 2 Years
Women with no breast cancer symptoms should undergo mammography screening every other year, according to a guidance statement from the American College of Physicians.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 9, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mother-of-two, 28, reveals how a hug with her son saved her life after spotting a lump
Emily Makin, of Greater Manchester, spotted a lump on her right breast while hugging her son, Harrison, three. A week later she was faced with a triple negative breast cancer diagnosis. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2019 Category: Consumer Health News Source Type: news

New guideline decreases breast cancer re-operation rates
(University of British Columbia Okanagan campus) A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients. Alex Monaghan, a second-year Southern Medical Program (SMP) student at UBC Okanagan, recently completed a study using patient data from BC Cancer-Kelowna. His research compared re-operation rates for breast cancer patients before and after a new surgical guideline was introduced five years ago. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2019 Category: Cancer & Oncology Source Type: news

Ovarian cancer patients undertested for mutations that could guide clinical care
(Stanford Medicine) Fewer than a quarter of breast cancer patients and a third of ovarian cancer patients diagnosed between 2013 and 2014 in two states underwent genetic testing for cancer-associated mutations, according to a study by researchers at the Stanford University School of Medicine and several other organizations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2019 Category: Cancer & Oncology Source Type: news

Jewish General Hospital pioneering new clinical trial to study treating breast cancer without surgery
(McGill University) In a radical departure from established treatment protocols, Dr. Mark Basik, a surgical oncologist at Segal Cancer Centre at the Jewish General Hospital (JGH) and senior investigator at the Lady Davis Institute, is leading an international effort that will lead to a clinical trial to forego surgery in breast cancer patients who show no signs of residual cancer following a course of pre-operative chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2019 Category: International Medicine & Public Health Source Type: news

New guidelines recommend less frequent mammograms for some women
Nearly 270,000 American women are expected to be diagnosed with breast cancer this year. This comes amid a debate and conflicting recommendations for mammograms. Now, there are new guidelines for some women. Dr. Tara Narula explains. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 9, 2019 Category: Consumer Health News Source Type: news

ACP pushes breast cancer screening start from 40 to 50
The American College of Physicians (ACP) has shifted its guidance on breast...Read more on AuntMinnie.comRelated Reading: DBT screening mammography benefits women over 65 Annual mammography shows higher recall rate Breast tissue seems less dense on DBT scans AI can reduce mammography screening's workload Is there an optimal mammography recall rate? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 9, 2019 Category: Radiology Source Type: news

AIUM: QUS shows promise for diagnostic ultrasound
ORLANDO, FL - Quantitative ultrasound (QUS) shows promise as an emerging mode...Read more on AuntMinnie.comRelated Reading: SBI: Don't overlook men when it comes to breast cancer Researchers test new ultrasound method for heart disease AI characterizes breast masses on ultrasound Study questions value of supplemental breast ultrasound Quantitative US gauges cellular tumor treatment response (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 9, 2019 Category: Radiology Source Type: news

Guidance Statements Issued for Breast Cancer Screening
Clinicians should discuss mammography with patients aged 40 to 49, discontinue screening for those ≥ 75 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 9, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Radiology, Journal, Source Type: news

Leading Group Of Doctors Makes New Mammogram Screening Recommendation
BOSTON (CBS) — A leading group of doctors has issued a new statement regarding breast cancer screening. The American College of Physicians (ACP) says that most women can start getting mammograms at age 50 and space them every two years. To be clear, these guidelines are intended for women who have no symptoms of breast cancer and do not have a higher risk of breast cancer, like a family history. Those women generally need to begin screening earlier and more frequently. But for women at average risk, the ACP says based on scientific evidence, women would benefit from screening starting at age 50 and continuing every o...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 9, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Breast Cancer Screening Dr. Mallika Marshall Mammograms Source Type: news

Most women need mammograms every other year starting at 50
Women at average risk for breast cancer can wait to start getting mammograms until age 50 and be screened every other year, according to new guidelines from the American College of Physicians. (Source: Reuters: Health)
Source: Reuters: Health - April 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

ACR, SBI rebuff new breast cancer screening guidelines
The American College of Radiology (ACR) and the Society of Breast Imaging (SBI)...Read more on AuntMinnie.comRelated Reading: ACP pushes breast cancer screening start from 40 to 50 SBI: Don't overlook men when it comes to breast cancer DBT screening mammography benefits women over 65 FDA proposes adding breast density reporting to MQSA Annual mammography shows higher recall rate (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 8, 2019 Category: Radiology Source Type: news

Guidance Statements Issued for Breast Cancer Screening
MONDAY, April 8, 2019 -- Four evidence-based guidance statements on breast cancer screening have been developed by the American College of Physicians and published online April 9 in the Annals of Internal Medicine. Amir Qaseem, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2019 Category: Pharmaceuticals Source Type: news